National Cancer Imaging Translational Accelerator (NCITA)

Committed to discovery, validation and delivery of innovative, practice-changing clinical imaging biomarkers for cancer patients.

Whether you require an Imaging Clinical Trials Unit to undertake multi-centre cancer imaging biomarker studies in the UK, or support from our Image Repository Unit or Quality Assurance Unit, our experienced NCITA team will strive to support your needs.

News Events Press

INTEGRATED INFRASTRUCTURE

NCITA is a UK national network of clinical research imaging infrastructures founded in 2019, supported by a Cancer Research UK Accelerator Award of up to £10 million over 5 years.

IMAGING Trial SUPPORT

Our integrated NCITA infrastructure provides support for multicentre cancer imaging biomarker trials using single and multimodality medical imaging technologies, quality assured imaging protocols and repository support. ..

NCITA PROJECTS

 Our Exemplar projects and projects adopted by the NCITA infrastructure aim to address areas of unmet clinical need by delivering standardised, quality assured imaging biomarkers for improving patient care. 

Our Vision

NCITA's vision is to accelerate the standardisation and clinical translation of cancer imaging biomarkers to improve diagnosis and healthcare outcomes for patients.